Literature DB >> 31542501

Mechanically tunable coaxial electrospun models of YAP/TAZ mechanoresponse and IGF-1R activation in osteosarcoma.

Eric R Molina1, Letitia K Chim1, Maria C Salazar1, Shail M Mehta2, Brian A Menegaz3, Salah-Eddine Lamhamedi-Cherradi3, Tejus Satish1, Sana Mohiuddin3, David McCall3, Ana Maria Zaske4, Branko Cuglievan3, Alexander J Lazar5, David W Scott6, Jane K Grande-Allen1, Joseph A Ludwig3, Antonios G Mikos7.   

Abstract

Current in vitro methods for assessing cancer biology and therapeutic response rely heavily on monolayer cell culture on hard, plastic surfaces that do not recapitulate essential elements of the tumor microenvironment. While a host of tumor models exist, most are not engineered to control the physical properties of the microenvironment and thus may not reflect the effects of mechanotransduction on tumor biology. Utilizing coaxial electrospinning, we developed three-dimensional (3D) tumor models with tunable mechanical properties in order to elucidate the effects of substrate stiffness and tissue architecture in osteosarcoma. Mechanical properties of coaxial electrospun meshes were characterized with a series of macroscale testing with uniaxial tensile testing and microscale testing utilizing atomic force microscopy on single fibers. Calculated moduli in our models ranged over three orders of magnitude in both macroscale and microscale testing. Osteosarcoma cells responded to decreasing substrate stiffness in 3D environments by increasing nuclear localization of Hippo pathway effectors, YAP and TAZ, while downregulating total YAP. Additionally, a downregulation of the IGF-1R/mTOR axis, the target of recent clinical trials in sarcoma, was observed in 3D models and heralded increased resistance to combination chemotherapy and IGF-1R/mTOR targeted agents compared to monolayer controls. In this study, we highlight the necessity of incorporating mechanical cues in cancer biology investigation and the complexity in mechanotransduction as a confluence of stiffness and culture architecture. Our models provide a versatile, mechanically variable substrate on which to study the effects of physical cues on the pathogenesis of tumors. STATEMENT OF SIGNIFICANCE: The tumor microenvironment plays a critical role in cancer pathogenesis. In this work, we engineered 3D, mechanically tunable, coaxial electrospun environments to determine the roles of the mechanical environment on osteosarcoma cell phenotype, morphology, and therapeutic response. We characterize the effects of varying macroscale and microscale stiffnesses in 3D environments on the localization and expression of the mechanoresponsive proteins, YAP and TAZ, and evaluate IGF-1R/mTOR pathway activation, a target of recent clinical trials in sarcoma. Increased nuclear YAP/TAZ was observed as stiffness in 3D was decreased. Downregulation of the IGF-1R/mTOR cascade in all 3D environments was observed. Our study highlights the complexity of mechanotransduction in 3D culture and represents a step towards controlling microenvironmental elements in in vitro cancer investigations.
Copyright © 2019 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Coaxial Electrospun Scaffolds; IGF-1R; Mechanically Tunable Scaffolds; Osteosarcoma; Tumor Model; YAP/TAZ

Mesh:

Substances:

Year:  2019        PMID: 31542501      PMCID: PMC7027943          DOI: 10.1016/j.actbio.2019.09.029

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  75 in total

1.  Phase II study of the mammalian target of rapamycin inhibitor ridaforolimus in patients with advanced bone and soft tissue sarcomas.

Authors:  Sant P Chawla; Arthur P Staddon; Laurence H Baker; Scott M Schuetze; Anthony W Tolcher; Gina Z D'Amato; Jean-Yves Blay; Monica M Mita; Kamalesh K Sankhala; Lori Berk; Victor M Rivera; Tim Clackson; John W Loewy; Frank G Haluska; George D Demetri
Journal:  J Clin Oncol       Date:  2011-11-07       Impact factor: 44.544

2.  Ridaforolimus (AP23573; MK-8669), a potent mTOR inhibitor, has broad antitumor activity and can be optimally administered using intermittent dosing regimens.

Authors:  Victor M Rivera; Rachel M Squillace; David Miller; Lori Berk; Scott D Wardwell; Yaoyu Ning; Roy Pollock; Narayana I Narasimhan; John D Iuliucci; Frank Wang; Tim Clackson
Journal:  Mol Cancer Ther       Date:  2011-04-11       Impact factor: 6.261

3.  IGF1R-targeted therapy and its enhancement of doxorubicin chemosensitivity in human osteosarcoma cell lines.

Authors:  Frederick Luk; Yan Yu; William R Walsh; Jia-Lin Yang
Journal:  Cancer Invest       Date:  2011-08-15       Impact factor: 2.176

4.  Cytoskeletal to Nuclear Strain Transfer Regulates YAP Signaling in Mesenchymal Stem Cells.

Authors:  Tristan P Driscoll; Brian D Cosgrove; Su-Jin Heo; Zach E Shurden; Robert L Mauck
Journal:  Biophys J       Date:  2015-06-16       Impact factor: 4.033

5.  β-Catenin/POU5F1/SOX2 transcription factor complex mediates IGF-I receptor signaling and predicts poor prognosis in lung adenocarcinoma.

Authors:  Chuan Xu; Dan Xie; Shi-Cang Yu; Xiao-Jun Yang; Li-Ru He; Jing Yang; Yi-Fang Ping; Bin Wang; Lang Yang; Sen-Lin Xu; Wei Cui; Qing-Liang Wang; Wen-Juan Fu; Qing Liu; Cheng Qian; You-Hong Cui; Jeremy N Rich; Hsiang-Fu Kung; Xia Zhang; Xiu-Wu Bian
Journal:  Cancer Res       Date:  2013-03-28       Impact factor: 12.701

6.  Look back in anger - what clinical studies tell us about preclinical work.

Authors:  Thomas Hartung
Journal:  ALTEX       Date:  2013       Impact factor: 6.043

7.  Microenvironmental Stiffness of 3D Polymeric Structures to Study Invasive Rates of Cancer Cells.

Authors:  Enrico Domenico Lemma; Barbara Spagnolo; Francesco Rizzi; Stefania Corvaglia; Marco Pisanello; Massimo De Vittorio; Ferruccio Pisanello
Journal:  Adv Healthc Mater       Date:  2017-11-06       Impact factor: 9.933

8.  Modeling Ewing sarcoma tumors in vitro with 3D scaffolds.

Authors:  Eliza Li Shan Fong; Salah-Eddine Lamhamedi-Cherradi; Emily Burdett; Vandhana Ramamoorthy; Alexander J Lazar; F Kurtis Kasper; Mary C Farach-Carson; Deeksha Vishwamitra; Elizabeth G Demicco; Brian A Menegaz; Hesham M Amin; Antonios G Mikos; Joseph A Ludwig
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-01       Impact factor: 11.205

Review 9.  Role of insulin-like growth factor 1 receptor signalling in cancer.

Authors:  O Larsson; A Girnita; L Girnita
Journal:  Br J Cancer       Date:  2005-06-20       Impact factor: 7.640

10.  Prognostic value of the Hippo pathway transcriptional coactivators YAP/TAZ and β1-integrin in conventional osteosarcoma.

Authors:  Corinne Bouvier; Nicolas Macagno; Quy Nguyen; Anderson Loundou; Carine Jiguet-Jiglaire; Jean-Claude Gentet; Jean-Luc Jouve; Alexandre Rochwerger; Jean-Camille Mattei; Daniel Bouvard; Sébastien Salas
Journal:  Oncotarget       Date:  2016-10-04
View more
  14 in total

1.  Biomaterial strategies for creating in vitro astrocyte cultures resembling in vivo astrocyte morphologies and phenotypes.

Authors:  Manoj K Gottipati; Jonathan M Zuidema; Ryan J Gilbert
Journal:  Curr Opin Biomed Eng       Date:  2020-07-04

2.  Modeling the Tumor Microenvironment and Pathogenic Signaling in Bone Sarcoma.

Authors:  Eric R Molina; Letitia K Chim; Sergio Barrios; Joseph A Ludwig; Antonios G Mikos
Journal:  Tissue Eng Part B Rev       Date:  2020-02-14       Impact factor: 6.389

Review 3.  Mechanoregulation of YAP and TAZ in Cellular Homeostasis and Disease Progression.

Authors:  Xiaomin Cai; Kuei-Chun Wang; Zhipeng Meng
Journal:  Front Cell Dev Biol       Date:  2021-05-24

Review 4.  In vitro three-dimensional cell cultures for bone sarcomas.

Authors:  Javier Munoz-Garcia; Camille Jubelin; Aurélie Loussouarn; Matisse Goumard; Laurent Griscom; Axelle Renodon-Cornière; Marie-Françoise Heymann; Dominique Heymann
Journal:  J Bone Oncol       Date:  2021-07-06       Impact factor: 4.072

Review 5.  Targeting Mechanotransduction in Osteosarcoma: A Comparative Oncology Perspective.

Authors:  Anita K Luu; Alicia M Viloria-Petit
Journal:  Int J Mol Sci       Date:  2020-10-14       Impact factor: 5.923

6.  The Clinical Significance and Potential Molecular Mechanism of Upregulated CDC28 Protein Kinase Regulatory Subunit 1B in Osteosarcoma.

Authors:  Chaohua Mo; Le Xie; Chang Chen; Jie Ma; Yingxin Huang; Yanxing Wu; Yuanyuan Xu; Huizhi Peng; Zengwei Chen; Rongjun Mao
Journal:  J Oncol       Date:  2021-12-10       Impact factor: 4.375

7.  Targeting the IGF/PI3K/mTOR pathway and AXL/YAP1/TAZ pathways in primary bone cancer.

Authors:  Danh D Truong; Salah-Eddine Lamhamedi-Cherradi; Joseph A Ludwig
Journal:  J Bone Oncol       Date:  2022-02-24       Impact factor: 4.072

Review 8.  Accounting for Material Changes in Decellularized Tissue with Underutilized Methodologies.

Authors:  Ryan A Behmer Hansen; Xinming Wang; Gitanjali Kaw; Valinteshley Pierre; Samuel E Senyo
Journal:  Biomed Res Int       Date:  2021-05-31       Impact factor: 3.246

9.  Simplified Brain Organoids for Rapid and Robust Modeling of Brain Disease.

Authors:  Jeongmin Ha; Ji Su Kang; Minhyung Lee; Areum Baek; Seongjun Kim; Sun-Ku Chung; Mi-Ok Lee; Janghwan Kim
Journal:  Front Cell Dev Biol       Date:  2020-10-28

10.  Transcriptional activators YAP/TAZ and AXL orchestrate dedifferentiation, cell fate, and metastasis in human osteosarcoma.

Authors:  Salah-Eddine Lamhamedi-Cherradi; Sana Mohiuddin; Dhruva K Mishra; Min P Kim; Joseph A Ludwig; Sandhya Krishnan; Alejandra Ruiz Velasco; Amelia M Vetter; Kristi Pence; David McCall; Danh D Truong; Branko Cuglievan; Brian A Menegaz; Budi Utama; Najat C Daw; Eric R Molina; Rafal J Zielinski; John A Livingston; Richard Gorlick; Antonios G Mikos
Journal:  Cancer Gene Ther       Date:  2021-01-06       Impact factor: 5.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.